Here are five key notes about the market:
1. The spine market in the United States is improving as fewer people delay procedures and implant price stabilizes.
2. LDR will likely gain the most next year with its Mobi-C gaining FDA approval for one and two level artificial disc replacements. The Mobi-C is the only artificial disc to have FDA clearance for both one and two levels.
3. Artificial disc replacement will likely account for a larger share of total disc cases, according to the report, with spine surgeons expecting that to increase to 12 percent over the next year and 17 percent in five years.
4. The number of cervical artificial disc cases is expected to grow 20 percent in 2015 to 2016.
5. LDR plans to hire 50 to 70 direct representatives by the end of the year, which could add to share gains for the company.
6. NuVasive is also poised for a good year in 2016 as one of the top share gainers in the spine implant space.
More articles on spine devices:
NuVasive Foundation surpasses $18M: More patients to receive spine surgery globally
SpineGuard DSG Threaded drill gets CE mark: 5 key notes
K2M commercially launches deformity spinal system in the US: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
